Virus-Like Particle Vaccines

Virus-Like Particle Vaccines

The structure, uniformity, stability, and functions of virus-like particles (VLPs) have encouraged scientists to utilize them as a unique tool in various applications in biomedical fields. Their interaction with the innate immune system is of major importance for the adaptive immune response they in...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Vogel, Monique
Sonstige:
Bachmann, Martin F
Vogel, Monique
Year of Publication:2020
Language:English
Physical Description:1 electronic resource (262 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993546296804498
ctrlnum (CKB)5400000000044319
(oapen)https://directory.doabooks.org/handle/20.500.12854/69086
(EXLCZ)995400000000044319
collection bib_alma
record_format marc
spelling Bachmann, Martin F edt
Virus-Like Particle Vaccines
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
1 electronic resource (262 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
The structure, uniformity, stability, and functions of virus-like particles (VLPs) have encouraged scientists to utilize them as a unique tool in various applications in biomedical fields. Their interaction with the innate immune system is of major importance for the adaptive immune response they induce. The innate immune cells and molecules recognize and interact with VLPs on the basis of two major characteristics: size and surface geometry. VLP-based vaccines against hepatitis B, human papilloma, malaria, and hepatitis E have been developed and are available in many countries around the world. Given the inherent immunogenicity of VLPs, they render themselves ideal for the development of new vaccines against infectious diseases as well as noncommunicable diseases, such as chronic inflammation or cancer. This Special Issue is designed to provide an up-to-date view of the latest progress in the development of VLP-based prophylactic and therapeutic vaccines and technologies for their generation.
English
Humanities bicssc
Social interaction bicssc
virus-like particle
influenza A(H1N1)pdm09
vaccination
pregnant women
antibody titers
norovirus
VLP
vaccine
genotype
pre-existing immunity
cross-reactivity
blocking antibodies
original antigenic sin (OAS)
HPVs
vaccines
virus-like particles (VLPs)
minor capsid protein (L2)
HCMV
cytomegalovirus
nanoparticle
immune response
Sudan virus
mice
horse
purified IgG
long-lived plasma cells
antibodies
multivalency
virus-like particles
antigenic analysis
epitope characterization
hepatitis E vaccine
serological evaluation
virion-like epitopes
well-characterized vaccines
hepatitis B virus
surface (envelope) antigen
sub-viral particle
capsid
antigen display
platform
viral quantification
NTA
flow virometry
SRFM
cryo-TEM
SEM
plant virus
virus-like
vaccine platform
epitope
antigen
cat allergy
Fel d 1
HypoCat™
IL-13
interleukin-13
Tfh cells
cancer
immunotherapy
H7N9
pandemic influenza A
avian flu
IAV
VLP vaccine
3-03943-074-2
3-03943-075-0
Vogel, Monique edt
Bachmann, Martin F oth
Vogel, Monique oth
language English
format eBook
author2 Vogel, Monique
Bachmann, Martin F
Vogel, Monique
author_facet Vogel, Monique
Bachmann, Martin F
Vogel, Monique
author2_variant m f b mf mfb
m v mv
author2_role HerausgeberIn
Sonstige
Sonstige
title Virus-Like Particle Vaccines
spellingShingle Virus-Like Particle Vaccines
title_full Virus-Like Particle Vaccines
title_fullStr Virus-Like Particle Vaccines
title_full_unstemmed Virus-Like Particle Vaccines
title_auth Virus-Like Particle Vaccines
title_new Virus-Like Particle Vaccines
title_sort virus-like particle vaccines
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2020
physical 1 electronic resource (262 p.)
isbn 3-03943-074-2
3-03943-075-0
illustrated Not Illustrated
work_keys_str_mv AT bachmannmartinf viruslikeparticlevaccines
AT vogelmonique viruslikeparticlevaccines
status_str n
ids_txt_mv (CKB)5400000000044319
(oapen)https://directory.doabooks.org/handle/20.500.12854/69086
(EXLCZ)995400000000044319
carrierType_str_mv cr
is_hierarchy_title Virus-Like Particle Vaccines
author2_original_writing_str_mv noLinkedField
noLinkedField
noLinkedField
_version_ 1787548505660719104
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03961nam-a2201105z--4500</leader><controlfield tag="001">993546296804498</controlfield><controlfield tag="005">20231214133353.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000044319</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/69086</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000044319</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bachmann, Martin F</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Virus-Like Particle Vaccines</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (262 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The structure, uniformity, stability, and functions of virus-like particles (VLPs) have encouraged scientists to utilize them as a unique tool in various applications in biomedical fields. Their interaction with the innate immune system is of major importance for the adaptive immune response they induce. The innate immune cells and molecules recognize and interact with VLPs on the basis of two major characteristics: size and surface geometry. VLP-based vaccines against hepatitis B, human papilloma, malaria, and hepatitis E have been developed and are available in many countries around the world. Given the inherent immunogenicity of VLPs, they render themselves ideal for the development of new vaccines against infectious diseases as well as noncommunicable diseases, such as chronic inflammation or cancer. This Special Issue is designed to provide an up-to-date view of the latest progress in the development of VLP-based prophylactic and therapeutic vaccines and technologies for their generation.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Humanities</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Social interaction</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">virus-like particle</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">influenza A(H1N1)pdm09</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vaccination</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pregnant women</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibody titers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">norovirus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">VLP</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vaccine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genotype</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pre-existing immunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cross-reactivity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">blocking antibodies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">original antigenic sin (OAS)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HPVs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vaccines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">virus-like particles (VLPs)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">minor capsid protein (L2)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HCMV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cytomegalovirus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanoparticle</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune response</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Sudan virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mice</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">horse</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">purified IgG</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">long-lived plasma cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibodies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multivalency</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">virus-like particles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antigenic analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epitope characterization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepatitis E vaccine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">serological evaluation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">virion-like epitopes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">well-characterized vaccines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepatitis B virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">surface (envelope) antigen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sub-viral particle</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">capsid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antigen display</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">platform</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">viral quantification</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NTA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">flow virometry</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SRFM</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cryo-TEM</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SEM</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">plant virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">virus-like</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vaccine platform</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epitope</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antigen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cat allergy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Fel d 1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HypoCat™</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IL-13</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">interleukin-13</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Tfh cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">H7N9</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pandemic influenza A</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">avian flu</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IAV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">VLP vaccine</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-074-2</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-075-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vogel, Monique</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bachmann, Martin F</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vogel, Monique</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:51:55 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338161600004498&amp;Force_direct=true</subfield><subfield code="Z">5338161600004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338161600004498</subfield></datafield></record></collection>

Similar Items